The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

This study has been completed.
Sponsor:
Collaborator:
Abu Dhabi Food Control Authority
Information provided by:
United Arab Emirates University
ClinicalTrials.gov Identifier:
NCT01307904
First received: March 2, 2011
Last updated: NA
Last verified: March 2010
History: No changes posted
  Purpose

The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study.

The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items.


Condition Intervention Phase
Diabetes Mellitus
Other: Glucose
Other: Dates
Phase 0

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Official Title: The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

Resource links provided by NLM:


Further study details as provided by United Arab Emirates University:

Primary Outcome Measures:
  • Dates Glycemic Index [ Time Frame: 4 months ] [ Designated as safety issue: No ]
    Measuring the composition of dates, selection of patients and carrying out the study


Enrollment: 23
Study Start Date: March 2010
Study Completion Date: July 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: dates
Each healthy and diabetic subjects received 50 grams equivalent of carbohydrates of the tested dates, On five separate days.
Other: Dates
Each healthy and diabetic volunteers received 50 grams equivalent of carbohydrates of each of the five selected dates, on five separate days.
Active Comparator: sugar
Each healthy and diabetic subjects received 50 grams of glucose
Other: Glucose
Each healthy and Diabetic volunteers received 50 grams of glucose

Detailed Description:

The United Arab Emirates (UAE) has transitioned rapidly over the last 40 years. This has lead to a dramatic increase in the prevalence of obesity, metabolic syndrome, dyslipidaemia, hypertension, prediabetes and diabetes. Daily consumption of dates is the norm.The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested equally in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study. The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items with potential health benefits for healthy and diabetic individuals alike.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adult
  • Healthy or having controlled type 2 diabetes mellitus

Exclusion Criteria:

  • Morbid obesity (BMI > 40)
  • Presence of gastroenterological disorders
  • Alimentary tract surgery
  • A history of gastroenteritis in the prior six months
  • Any disease that may affect glucose metabolism
  • Alcohol intake
  • Smoking
  • Taking any medications (except metformin)
  • Poorly uncontrolled diabetes (HbA1c > 8%)
  • The presence of chronic diseases or the presence of acute illness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01307904

Locations
United Arab Emirates
Internal Medicine Department, FMHS, UAE University
Al Ain, Abu Dhabi, United Arab Emirates
Sponsors and Collaborators
United Arab Emirates University
Abu Dhabi Food Control Authority
Investigators
Principal Investigator: Juma M Alkaabi, MD Faculty of Medicine and Health Sciences, UAE University
Study Director: Bayan Al-Dabbagh, PhD Faculty of Medicine and Health Sciences, UAE University
Study Director: Professor Hussein saadi, MD Faculty of Medicine and Health Sciences, UAE University
Study Director: Professor Salah Gariballa, FRCP Faculty of Medicine and Health Sciences, UAE University
Study Director: Ahmed Shakeel, PhD Abu Dhabi Food Control Authority
Study Director: Mustafa Al Gazali, PhD Abu Dhabi Food Control Authority
  More Information

No publications provided by United Arab Emirates University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Juma M Alkaabi, Faculty of Medicine and Health Sciences - UAE University
ClinicalTrials.gov Identifier: NCT01307904     History of Changes
Other Study ID Numbers: UAEU Dates GI Study
Study First Received: March 2, 2011
Last Updated: March 2, 2011
Health Authority: United Arab Emirates:Office of Research and Graduate Studies,Faculty of Medicine& Health Sciences

Keywords provided by United Arab Emirates University:
Glycemic index
Dates
Blood glucose

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on September 16, 2014